Wu C X, Zhang T, Shu L, Huang J, Diao F Y, Ding W, Gao Y, Wang W, Mao Y D, Cui Y G, Liu J Y
Center of Reproductive Medicine, First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China.
Zhonghua Fu Chan Ke Za Zhi. 2018 Mar 25;53(3):160-166. doi: 10.3760/cma.j.issn.0529-567X.2018.03.004.
Using of cumulative live birth rate (CLBR) per oocytes retrieved cycle, to assess the clinical outcomes of in vitro fertilization or intracytoplasmic sperm injection (IVF/ICSI) , and to explore impact factors on CLBR following utilization of all fresh and frozen embryos in one complete IVF/ICSI cycle using gonadotropin-releasing hormone (GnRH) agonist, GnRH-antagonist and clomiphene mild stimulation protocols. Of the patients who underwent IVF/ICSI from January 1st, 2014 to December 31st, 2015 in the First Affiliated Hospital, Nanjing Medical University, a total of 6 142 oocytes retrieved cycles were included. The clinical and laboratory parameters of different ovarian stimulation protocols, and the effects of the age, number of oocytes retrieved and number of embryos available on the CLBR of each oocytes retrieved cycle were analyzed. The CLBR was 69.0% (2 004/2 906) in the GnRH-agonist protocol versus 67.4% (644/955) in the GnRH-antagonist protocol (0.05); the CLBR of clomiphene mild stimulation protocol was 53.2% (1 215/2 281) , significantly lower than those of the other two protocols (all 0.05). The CLBR significantly decreased with age increased. When divided into four groups according to the patients' age, we found that CLBR were not statistically significant using three different protocols in the 20-25 years old group (all 0.05). There was a strong association between the number of oocytes retrieved and embryos available on CLBR. CLBR rose significantly with an increasing number of oocytes up to 6, then the rising trend slowed down. Patients were categorized into four groups according to the number of oocytes retrieved, CLBR was significantly higher using GnRH-antagonist protocol (50.0%) than mild stimulation protocol (37.0%) in low ovarian responder (0-4 oocytes) group (0.05) . The CLBR were no significant difference among three protocols in normal (10-15 oocytes) and high responders (≥15 oocytes) group (all 0.05) . The incidence rate of ovarian hyperstimulation syndrome in GnRH-agonist protocols (5.2%, 152/2 906) were significantly higher than those of GnRH-antagonist (4.4%, 42/955) and clomiphene mild stimulation protocols (1.5%, 34/2 281; all 0.05) . CLBR is an important index to assess the clinical outcomes of IVF/ICSI. Age, number of oocytes retrieved and embryos available could affect CLBR obviously. According to the different age and ovarian response of patients, we should design ovarian stimulation protocols based on target oocytes number in order to get higher CLBR and reduce complications.
采用每个取卵周期的累积活产率(CLBR)来评估体外受精或卵胞浆内单精子注射(IVF/ICSI)的临床结局,并探讨在一个完整的IVF/ICSI周期中使用促性腺激素释放激素(GnRH)激动剂、GnRH拮抗剂和克罗米芬温和刺激方案后,利用所有新鲜和冷冻胚胎对CLBR的影响因素。在南京医科大学第一附属医院2014年1月1日至2015年12月31日接受IVF/ICSI治疗的患者中,共纳入6142个取卵周期。分析了不同卵巢刺激方案的临床和实验室参数,以及年龄、取卵数和可用胚胎数对每个取卵周期CLBR的影响。GnRH激动剂方案的CLBR为69.0%(2004/2906),而GnRH拮抗剂方案为67.4%(644/955)(P>0.05);克罗米芬温和刺激方案的CLBR为53.2%(1215/2281),显著低于其他两种方案(均P<0.05)。CLBR随年龄增加而显著降低。根据患者年龄分为四组,我们发现20 - 25岁组使用三种不同方案的CLBR无统计学差异(均P>0.05)。取卵数和可用胚胎数与CLBR之间存在密切关联。CLBR随着取卵数增加至6个时显著上升,然后上升趋势放缓。根据取卵数将患者分为四组,在低卵巢反应者(0 - 4个卵母细胞)组中,GnRH拮抗剂方案的CLBR(50.0%)显著高于温和刺激方案(37.0%)(P<0.05)。在正常反应者(10 - 15个卵母细胞)和高反应者(≥15个卵母细胞)组中,三种方案的CLBR无显著差异(均P>0.05)。GnRH激动剂方案的卵巢过度刺激综合征发生率(5.2%,152/2906)显著高于GnRH拮抗剂方案(4.4%,42/955)和克罗米芬温和刺激方案(1.5%,34/2281;均P<0.05)。CLBR是评估IVF/ICSI临床结局的重要指标。年龄、取卵数和可用胚胎数可明显影响CLBR。应根据患者的不同年龄和卵巢反应,以目标卵母细胞数为基础设计卵巢刺激方案,以获得更高的CLBR并减少并发症。